dc.contributor.author |
Kajungu, D. K. |
en_US |
dc.contributor.author |
Erhart, A. |
en_US |
dc.contributor.author |
Talisuna, A. O. |
en_US |
dc.contributor.author |
Bassat, Q. |
en_US |
dc.contributor.author |
Karema, C. |
en_US |
dc.contributor.author |
Nabasumba, C. |
en_US |
dc.contributor.author |
Nambozi, M. |
en_US |
dc.contributor.author |
Tinto, H. |
en_US |
dc.contributor.author |
Kremsner, P. |
en_US |
dc.contributor.author |
Meremikwu, M. |
en_US |
dc.contributor.author |
D'Alessandro, U. |
en_US |
dc.contributor.author |
Speybroeck, N. |
en_US |
dc.date.accessioned |
2014-09-25T13:39:50Z |
|
dc.date.available |
2014-09-25T13:39:50Z |
|
dc.date.issued |
2014 |
en_US |
dc.identifier.issn |
1932-6203 |
en_US |
dc.identifier.doi |
http://dx.doi.org/10.1371/journal.pone.0096388 |
en_US |
dc.identifier.other |
ITG-B2A; ITG-H11A; MULTI; DBM; U-MALAR; DPH; U-ECMAL; ZRB; JIF; DOI; FTA; E-only; OAJ; UPD56 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10390/7909 |
|
dc.language |
English |
en_US |
dc.subject |
Protozoal diseases |
en_US |
dc.subject |
Malaria |
en_US |
dc.subject |
Plasmodium falciparum |
en_US |
dc.subject |
Vectors |
en_US |
dc.subject |
Mosquitoes |
en_US |
dc.subject |
Anopheles |
en_US |
dc.subject |
Control |
en_US |
dc.subject |
Drugs |
en_US |
dc.subject |
Pharmaceutical products |
en_US |
dc.subject |
Safety |
en_US |
dc.subject |
Monitoring |
en_US |
dc.subject |
Adverse effects |
en_US |
dc.subject |
Data collection |
en_US |
dc.subject |
Algorithms |
en_US |
dc.subject |
Artemisinin combination therapies (ACT) |
en_US |
dc.subject |
ACT |
en_US |
dc.subject |
Amodiaquine |
en_US |
dc.subject |
Artesunate |
en_US |
dc.subject |
Dihydroartemisinin-piperaquine |
en_US |
dc.subject |
Artemether-lumefantrine |
en_US |
dc.subject |
Chlorproguanil |
en_US |
dc.subject |
Dapsone |
en_US |
dc.subject |
Clinical trials |
en_US |
dc.subject |
Children |
en_US |
dc.subject |
Africa, West |
en_US |
dc.subject |
Africa, Central |
en_US |
dc.subject |
Africa, East |
en_US |
dc.title |
Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries |
en_US |
dc.type |
Article-E |
en_US |
dc.citation.issue |
5 |
en_US |
dc.citation.jtitle |
PLoS ONE |
en_US |
dc.citation.volume |
9 |
en_US |
dc.citation.pages |
e96388 |
en_US |
dc.identifier.pmid |
http://www.ncbi.nlm.nih.gov/pubmed/24787710 |
en_US |
dc.citation.jabbreviation |
PLoS ONE |
en_US |